2020 Updates in Care of the Hematologic Malignancies Patient: With Proceedings from International Medical Meetings

LIVECMECNEConferences & Symposia

Add to Calendar 2020 Updates in Care of the Hematologic Malignancies Patient: With Proceedings from International Medical Meetings 1/31/2020 7:30:00 AM 1/31/2020 4:30:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/2020UPDATES Description: This course is a comprehensive review of hematologic malignancies focusing on research developments over the preceding year and their application to the patient care journey. Didactic presentations will include case discussion with Penn faculty and community experts. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of pa... THE RITTENHOUSE false MM/DD/YYYY


Friday, January 31, 2020, 7:30 AM - 4:30 PM ET, THE RITTENHOUSE


This course is a comprehensive review of hematologic malignancies focusing on research developments over the preceding year and their application to the patient care journey. Didactic presentations will include case discussion with Penn faculty and community experts. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application.


Specialties - CLINICAL CYTOGENETICS AND GENOMICS, INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, PATHOLOGY - Cytopathology, PATHOLOGY - Hematopathology, PATHOLOGY - Pathology-Molecular Genetic


Objectives
  1. Identify clinical features, including differential diagnoses for the various hematologic malignancies
  2. Implement strategies that incorporate state-of-the-art genomic analyses for hematologic malignancies
  3. Select patients with potential eligibility for immunotherapy
  4. List appropriate clinical trials for hematologic malignancies
  5. Identify the major patient management issues experienced by the interprofessional care team associated with hematologic malignancies
  6. Apply new strategies for incorporating therapies that target metabolism in blood cancers


In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit



AMA PRA Category 1 Credits™ (7.50 hours), NCPD Hours (ANCC) (7.50 hours), Non-Physician Attendance / Participation (7.50 hours)